Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. CCIC Huatongwei International Inspection Co., Ltd.
WARNING LETTER
•CCIC Huatongwei International Inspection Co., Ltd.•January 14, 2025

CCIC Huatongwei International Inspection Co., Ltd. – FDA Warning Letter, Jan 14, 2025

Record Details

**FDA Warning Letter Summary: CCIC Huatongwei International Inspection (Suzhou) Co., Ltd.**

**Company Name:** CCIC Huatongwei International Inspection (Suzhou) Co., Ltd.

**Inspection Dates:** January 6, 2025, to January 14, 2025

**Main Violations/Issues:** The FDA inspection revealed significant non-compliance with Good Laboratory Practice (GLP) regulations, specifically under Title 21, CFR Part 58. Key violations include:

1. **Data Integrity Issues:** The study director failed to ensure that experimental data were accurately recorded and verified. Instances were found where source data were photocopied and reused across different studies, compromising data integrity.

2. **Use of Templates:** Templates with pre-completed information were used for final reports, leading to inaccuracies and lack of study-specific data.

3. **Archival Deficiencies:** Required study records were not archived in a timely manner. Modifications to study folders were made shortly before the inspection, indicating potential data manipulation.

**Regulatory Framework:** The inspection was conducted under a program to ensure data validity in submissions for Investigational Device Exemption, Premarket Approval, and Premarket Notification. Compliance with GLP regulations is crucial to assure the quality and integrity of safety data.

**Required Actions:** The FDA requires CCIC Huatongwei to:

- Implement corrective actions to ensure accurate recording and verification of all experimental data. - Cease the use of pre-completed templates and ensure all reports are study-specific. - Establish robust archival practices to ensure timely and complete data retention.

Failure to address these issues could result in regulatory actions, including rejection of data in future submissions. The company must respond with a detailed corrective action plan to address these violations.

Company
CCIC Huatongwei International Inspection Co., Ltd.
Inspection date
January 14, 2025
Product type
Devices
Office
Center for Devices and Radiological Health
Person
  • Soma Kalb (Division Director)
View Company Profile

ID · c2933ab0-6726-4684-aa38-1c102d35a839

Violation Codes10
FD&C Act 201(h)(1)21 U.S.C. 321(h)(1)21 CFR 58FD&C Act 520(g)21 U.S.C. 360j(g)21 CFR 58.33(b)21 CFR 58.33(f)21 CFR 58.130(c)21 CFR 58.90(d)21 CFR 58.130(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore CCIC Huatongwei International Inspection Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.